Allergen-specific immunotherapy in patients with atopic dermatitis?;Hyposensibilisierung bei patienten mit atopischer dermatitis?

Allergologie

Volumn 30, Issue 11, 2007, Pages 405-410

  Bussmann C ^a   Novak, N ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Allergens; Atopic dermatitis; House dust mites; Specific immunotherapy

Indexed keywords

ALLERGIC ASTHMA; ATOPIC DERMATITIS; CLINICAL FEATURE; DERMATOPHAGOIDES; DISEASE COURSE; HUMAN; IMMUNOTHERAPY; PREVENTION AND CONTROL; RECURRENT DISEASE; REVIEW; SENSITIZATION;

EID: 36849070940     PISSN: 03445062     EISSN: None     Source Type: Journal    
DOI: 10.5414/ALP30405     Document Type: Review

References (61)

1. Arlian L.G., T.A. Platts-Mills: The biology of dust mites and the remediation of mite allergens in allergic disease. J. Allergy Clin. Immunol. 107, S406-S413 (2001).
2. Brown A., K. Farmer, L. MacDonald, N. Kalsheker, D. Pritchard, C. Haslett, J. Lamb, J.M. Sallenave: House dust mite Der p 1 downregulates defenses of the lung by inactivating elastase inhibitors. Am. J. Respir. Cell Mol. Biol. 29, 381-389 (2003).
3. Bruun E.: Control examination of the specificity of specific desensitization in asthma. Acta Allergol. 2, 122-128 (1949)
4. Bussmann C., L. Maintz, J. Hart, J.P. Allam S. Vrtala, C. Kuan-Wei, R.T. Wayne, R. Valenta, T. Zuberbier, A. Sager, N. Novak: Clinical improvement and immunological changes of atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid - a pilot study. Clin. Exp. Allergy 37, 1277-1285 (2007).
5. Bussmann C., A. Bockenhoff, H. Henke, T. Werfel, N. Novak: Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis? J. Allergy Clin. Immunol. 118, 1292-1298 (2006).
6. Celedon J.C., D.K. Milton, C.D. Ramsey, A.A. Litonjua, L. Ryan, T.A. Platts-Mills, D.R. Gold: Exposure to dust mite allergen and endotoxin in early life and asthma and atopy in childhood. J. Allergy Clin. Immunol. 120, 144-149 (2007).
7. Chait I., V. Allkins: Remission of life-long atopic dermatitis after hyposensitisation to house dust mite. Practitioner 229, 609-612 (1985).
8. Cork M.J., D.A. Robinson, Y. Vasilopoulos, A. Ferguson, M. Moustafa, A. MacGowan, G.W. Duff, S.J. Ward, R. Tazi-Ahnini: New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J. Allergy Clin. Immunol. 118, 3-21 (2006).
9. Corrado O.J., E. Pastorello, S. Ollier, L. Cresswell, C. Zanussi, C. Ortolani, A. Incorvaia, A. Fugazza, J.R. Lovely, R.I. Harris: A double-blind study of hyposensitization with an alginate-conjugated extract of D. pteronyssinus (Conjuvac) in patients with perennial rhinitis. 1. Clinical aspects. Allergy 44, 108-115 (1989).
10. Di Prisco de Fuenmayor M.C., R.H. Champion: Specific hyposensitization in atopic dermatitis. Br. J. Dermatol. 101, 697-700 (1979).
11. Engelhart S., T. Bieber, M. Exner: House dust mite allergen levels in German day-care centers. Int. J. Hyg. Environ. Health 205, 453-457 (2002).
12. Galli E., L. Chini, S. Nardi, N. Benincori, P. Panei, G. Fraioli, V. Moschese, P. Rossi: Use of a specific oral hyposensitization therapy to Dermatophagoides pteronyssinus in children with atopic dermatitis. Allergol. Immunopathol. (Madr.) 22, 18-22 (1994).
13. Garcia C., D. El-Qutob, A. Martorell, I. Febrer, M. Rodriguez, J.C. Cerda, R. Felix: Sensitization in early age to food allergens in children with atopic dermatitis. Allergol. Immunopathol. (Madr.) 35, 15-20 (2007).
14. Glover M.T., D.J. Atherton: A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema. Clin. Exp. Allergy 22, 440-446 (1992).
15. Grembiale R.D., L. Camporota, S. Naty, C.M. Tranfa, R. Djukanovic, S.A. Marsico: Effects of specific immunotherapy in allergic rhinitic individuals with bronchial hyperresponsiveness. Am. J. Respir. Crit. Care Med. 162, 2048-2052 (2000).
16. Grewe M.: Hyposensibilisierung beim atopischen Ekzem. Allergo J. 9, 351-353 (2000).
17. Gutgesell C., S. Heise, S. Seubert, A. Seubert, S. Domhof, E. Brunner, C. Neumann: Double-blind placebo-controlled house dust mite control measures in adult patients with atopic dermatitis. Br. J. Dermatol. 145, 70-74 (2001).
18. Heijer A.: Hyposensitzation with aeroallergens in atopic eczema. Allergo J. 2, 3-7 (1993).
19. Htut T., T.W. Higenbottam, G.W. Gill, R. Darwin, P.B. Anderson, N. Syed: Eradication of house dust mite from homes of atopic asthmatic subjects: a double-blind trial. J. Allergy Clin. Immunol. 107, 55-60 (2001).
20. Huss-Marp J., B. Eberlein-Konig, K. Breuer, S. Mair, A. Ansel, U. Darsow, U. Kramer, E. Mayer, J. Ring, H. Behrendt: Influence of short-term exposure to airborne Der p 1 and volatile organic compounds on skin barrier function and dermal blood flow in patients with atopic eczema and healthy individuals. Clin. Exp. Allergy 36, 338-345 (2006).
21. Ibero M., M.J. Castillo: Significant improvement of specific bronchial hyperreactivity in asthmatic children after 4 months of treatment with a modified extract of Dermatophagoides pteronyssinus. J. Invest. Allergol. Clin. Immunol. 16, 194-202 (2006).
22. Kaufman H.S., H.L. Roth: Hyposensitization with alum-precipitated extracts in atopic dermatitis: a placebo-controlled study. Ann. Allergy 32, 321-330 (1974).
23. Kawabata A., N. Kawao: Physiology and pathophysiology of proteinase-activated receptors (PARs): PARs in the respiratory system: cellular signaling and physiological/pathological roles. J. Pharm. Sci. 97, 20-24 (2005).
24. Kleine-Tebbe J., K.C. Bergmann, F. Friedrichs, T. Fuchs, K. Jung, L. Klimek: Die spezifische Immuntherapie (Hyposensiblisierung) bei IgE-vermittelten allergischen Erkrankungen. Allergo J. 15, 56-74 (2006).
25. Leroy B.P., G. Boden, J.M. Lachapelle, M.G. Jacquemin, J.M. Saint-Remy: A novel therapy for atopic dermatitis with allergen-antibody complexes: a double-blind, placebo-controlled study. J. Am. Acad. Dermatol. 28, 232-239 (1993).
26. Leung D.Y., M. Boguniewicz, M.D. Howell, I. Nomura, Q.A. Hamid: New insights into atopic dermatitis. J. Clin. Invest. 113, 651-657 (2004).
27. Mastrandrea F., G. Serio, M. Minelli, A. Minardi, G. Scarcia, G. Coradduzza, S. Parmiani: Specific sublingual immunotherapy in atopic dermatitis. Results of a 6-year follow-up of 35 consecutive patients. Allergol. Immunopathol. 28, 54-62 (2000).
28. Mehl A., C. Rolinck-Werninghaus, U. Staden, A. Verstege, U. Wahn, K. Beyer, B. Niggemann: The atopy patch test in the diagnostic workup of suspected food-related symptoms in children. J. Allergy Clin. Immunol. 118, 923-929 (2006).
29. Michils A., C.M. Farber, J.P. Van Vooren, J.C. Yernault, J. Duchateau: Sustained benefit of interferon-α therapy and oral hyposensitization in severe atopic dermatitis. Br. J. Dermatol. 130, 134-135 (1994).
30. Morar N., S.A. Willis-Owen, M.F. Moffatt, W.O. Cookson: The genetics of atopic dermatitis. J. Allergy Clin. Immunol. 118, 24-34 (2006).
31. Mosca M., G. Albani-Rochetti, M.A. Vigini, S. Ubezio, G. Nume, A. Di Silverio: La vaccinoterapia sublinguale nella dermatitie atopica. Ital. Dermatol. Venereol. 128, 79-83 (1993).
32. Noh G.W., K.Y. Lee: Blood eosinophils and serum IgE as predictors for prognosis of interferon-γ therapy in atopic dermatitis. Allergy 53, 1202-1207 (1998).
33. Ohashi Y., Y. Nakai, T. Ayaki, Y. Kakinoki, Y. Washio, Y. Ohno, K. Yamada, Y. Nasako: Risk factors for adverse systemic reactions occurring during immunotherapy with standardized Dermatophagoides farina extracts. Acta Otolaryngol. 538, 113-117 (1998).
34. Oosting A.J., M.S. de Bruin-Weller, I. Terreehorst, Z. Tempels-Pavlica, R.C. Aalberse, J.G. de Monchy, R.G. van Wijk, C.A. Bruijnzeel-Koomen: Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: the Dutch mite avoidance study. J. Allergy Clin. Immunol. 110, 500-506 (2002).
35. Pacor M.L., D. Biasi, T. Maleknia: The efficacy of long-term specific immunotherapy for Dermatophagoides pteronyssinus in patients with atopic dermatitis. Recenti Prog. Med. 85, 273-277 (1994).
36. Pajno G.B., L. Caminiti, D. Vita, G. Barberio, G. Salzano, F. Lombardo, G.W. Canonica, G. Passalacqua: Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J. Allergy Clin. Immunol. 120, 164-170 (2007).
37. Petrova S.I., V.M. Berzhets, V.I. Albanova, T.F. Bystriskkaia, N.S. Petrova: Immunotherapy in the complex treatment of patients with atopic dermatitis with sensitization to house dust mites. Zh. Mikrobiol. Epidemiol. Immunobiol. 1, 33-36 (2006).
38. Platts-Mills T.A., W.R. Thomas, R.C. Aalberse, D. Vervloet, M.D. Champman: Dust mite allergens and asthma: report of a second international workshop. J. Allergy Clin. Immunol. 89, 1046-1060 (1992).
39. Ring J.: Successful hyposensitization treatment in atopic eczema: results of a trial in monozygotic twins. Br. J. Dermatol. 107, 597-602 (1982).
40. Rolinck-Werninghaus C., E. Hamelmann, T. Keil, M. Kulig, K. Koetz, B. Gerstner, J. Kuehr, S. Zielen, U. Schauer, W. Kamin, B.A. Von, J. Hammermann, B. Weinkauf, G. Weidinger, S. Stenglein, U. Wahn: The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children. Allergy 59, 973-979 (2004).
41. Schmid-Grendelmeier P., A. Scheynius, R. Crameri: The role of sensitization to Malassezia sympodialis in atopic eczema. Chem. Immunol. Allergy 91, 98-109 (2006).
42. Schmid-Grendelmeier P., D. Simon, H.H. Simon, C.A. Akdis, B. Wüthrich: Epidemiology, clinical features, and immunology of the "intrinsic" (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis). Allergy 56, 841-849 (2001).
43. Seidenari S., M. Mosca, M. Taglietti, S. Manco, G. Nume: Specific hyposensitization in atopic dermatitis. Dermatologica 172, 229 (1986).
44. Silny W., M. Czarnecka-Operacz: Spezifische Immuntherapie bei der Behandlung von Patienten mit atopischer Dermatitis. Allergologie 29, 171-183 (2006).
45. Silny W., M. Czarnecka-Operacz, P. Silny: Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis. Part I.: Evaluation of clinical score. Wiad. Lek. 58, 47-55 (2005).
46. Simpson E.L., J.M. Hanifin: Atopic dermatitis. Med. Clin. North Am. 90, 149-167 (2006).
47. Smith A.P.: Hyposensitization with Dermatophagoides pteronyssinus antigen: trial in asthma induced by house dust. Br. Med. 23, 204-206 (1971).
48. Spergel J.M., A.S. Paller: Atopic dermatitis and the atopic march. J. Allergy Clin. Immunol. 112, S118-S127 (2003).
49. Strange P., L. Skov, S. Lisby, P.L. Nielsen, O. Baadsgaard: Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch. Dermatol. 132, 27-33 (1996).
50. Tan B.B., D. Weald, I. Strickland, P.S. Friedmann: Double-blind controlled trial of effect of house-dust-mite allergen avoidance on atopic dermatitis. Lancet 347, 15-18 (1996).
51. Terreehorst I., E. Hak, A.J. Oosting, Z. Tempels-Pavlica, J.G. de Monchy, C.A. Bruijnzeel-Koomen, R.C. Aalberse, W.R. van Gerth: Evaluation of impermeable covers for bedding in patients with allergic rhinitis. N. Engl. J. Med. 349, 237-246 (2003).
52. Till S.J., J.N. Francis, K. Nouri-Aria, S.R. Durham: Mechanisms of immunotherapy. J. Allergy Clin. Immunol. 113, 1025-1034 (2004).
53. Trofimowicz A., E. Rzepecka, J. Hofman: Clinical effects of specific immunotheraphy in children with atopic dermatitis. Rocz. Akad. Med. Bialymst. 40, 414-422 (1995).
54. Tupker R.A., J.G. de Monchy, P.J. Coenraads, A. Homan, J.B. van der Meer: Induction of atopic dermatitis by inhalation of house dust mite. J. Allergy Clin. Immunol. 97, 1064-1070 (1996).
55. Verhagen J., A. Taylor, K. Blaser, M. Akdis, C.A. Akdis: T-regulatory cells in allergen-specific immunotherapy. Int. Rev. Immunol. 24, 533-548 (2005).
56. Warner A., S. Bostrom, C. Moller, N.I. Kjellman: Mite fauna in the home and sensitivity to house-dust and storage mites. Allergy 54, 681-690 (1999).
57. Warner J.O., J.F. Price, J.F. Soothill, E.N. Hey: Controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with asthma. Lancet 2, 912-915 (1978).
58. Werfel T., K. Breuer, F. Rueff, B. Przyhilla, M. Worm, M. Grewe, T. Ruzicka, R. Brehler, H. Wolf, J. Schnitker, A. Kapp: Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy 61, 202-205 (2006).
59. Werfel T., A. Morita, M. Grewe, N. Renz, U. Wahn, J. Krutmann, A. Kapp: Allergen specificity of skin-infiltrating T cells is not restricted to a Type-2 cytokine pattern in chronic skin lesions of atopic dermatitis. J. Invest. Dermatol. 106, 871-876 (1996).
60. Zachariae H., M. Cramers, T. Herlin, J. Jensen, K. Kragballe, T. Ternowitz, K. Thestrup-Pedersen: Non-specific immunotherapy and specific hyposensitization in severe atopic dermatitis. Acta Derm. Venereol. Stockh. Suppl. 14, 48-54 (1985).
61. Zwacka G., S. Glaser, B. Rieger: Therapeutische Erfahrungen mit Pangramin-SLIT im Vergleich zu einer subkutanen Immuntherapie und zur syptomatischen medikamentösen Behandlung bei Kindern mit Asthma bronchiale, Rhinokonjunktivitis und atopischer Dermatitis. Allergologie 19, 580-592 (1996).